Loading...
Market
Story
Japan's PHDP5 Peptide Reverses Alzheimer’s Symptoms in Mice
Jun 24, 2024, 02:01 PM
Researchers at the Okinawa Institute of Science and Technology (OIST) in Japan have developed a synthetic peptide, PHDP5, that successfully reversed Alzheimer’s symptoms in mice. The peptide targets and improves brain synaptic function, effectively restoring cognitive function and memory by reversing synapse damage. Treated mice exhibited the same cognitive function as healthy mice, highlighting the potential of PHDP5 to cross the blood-brain barrier and offer a new therapeutic approach for Alzheimer’s disease.
View original story
Similar markets
Yes • 50%
No • 50%
Significant improvement • 25%
Moderate improvement • 25%
No improvement • 25%
Worse outcomes • 25%
Positive results with MRD-negative CR • 25%
Mixed results • 25%
Negative results • 25%
Trial discontinued • 25%
Successful with no adverse effects • 25%
Successful with minor adverse effects • 25%
Unsuccessful • 25%
Trial halted due to safety concerns • 25%
Positive results • 25%
Negative results • 25%
Inconclusive results • 25%
Trial not completed • 25%
Highly Effective • 25%
Moderately Effective • 25%
Minimally Effective • 25%
Ineffective • 25%
Positive results for B-cell malignancies • 25%
Positive results for autoimmune diseases • 25%
Negative results for both • 25%
Mixed results • 25%
Significant improvement • 25%
Moderate improvement • 25%
No improvement • 25%
Worsening condition • 25%
